Oncopeptides SEK 1.1 billion private placing of new shares
We advised Oncopeptides on the private placement of shares
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Manchester United offering of Class A ordinary shares
We advised the underwriter on the secondary offering
RSA investment by Clearlake Capital
We are advising RSA on the investment
Bandwidth $250 million convertible senior notes offering
We advised the initial purchasers on the Rule 144A convertible notes offering
eToro Group $650 million PIPE investment
We advised the placement agents on the private placement
Hayward Holdings $684.7 million IPO
The shares are listed on the New York Stock Exchange
Oak Street Health $920 million convertible senior notes offering
We advised the initial purchasers on the Rule 144A offering
Prometheus Biosciences $218.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Financial planning firm $455 million holdco loan
We advised the lenders on the transaction
Avid Bioservices $143.8 million exchangeable senior notes offering
We advised the initial purchasers on the Rule 144A offering